Healthcare · head to head
Annalise.ai vs Meru Health

Annalise.ai
Healthcare
Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model
- From
- On request
- Rated
- -

Meru Health
Healthcare
Twelve week therapist led mental health programme combining an app, a clinician and HRV biofeedback
- From
- On request
- Rated
- -
The short version
- Each has a real cost: Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.; Meru Health the programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.
- They diverge on capability: Annalise.ai covers Annalise Enterprise CXR, Meru Health covers Twelve week structured programme.
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which Annalise.ai and Meru Health actually diverge.
| Attribute | Annalise.ai | Meru Health |
|---|---|---|
| Platforms | Web, Cloud, On-premise | Web, iOS, Android |
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Annalise.ai
- Annalise Enterprise CXR
- Annalise Enterprise CTB
- Triage and notification
- Worklist reprioritisation
- Localisation overlays
- Confidence output
- PACS-native deployment
- On-premise or cloud inference
Only in Meru Health
- Twelve week structured programme
- Licensed therapist
- Psychiatric consultation
- HRV biofeedback device
- Daily in app practice
- Meru Health Advanced
- Payer contracting
- Outcome measurement
What people use each for
The jobs each tool is most often brought in to do.
Annalise.ai
- An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Meru Health
- A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Meru Health
- A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Meru Health
- A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Meru Health
Meru Health
- A health plan that wants a mental health intervention it can underwrite as a bounded episode rather than an open ended benefitnot Annalise.ai
- An employer whose staff need treatment rather than wellbeing content, with a therapist and a prescriber in one pathwaynot Annalise.ai
- A member who needs medication review alongside therapy, which most app based mental health products cannot providenot Annalise.ai
- A health system seeking to offload moderate depression and anxiety from a psychiatry service with long waitsnot Annalise.ai
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Annalise.ai
- The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
- Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
- Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
- The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
- A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.
Meru Health
- The programme is twelve weeks and then it ends, which fits an episode of treatment but not a chronic condition needing maintenance, so relapse after week twelve lands on whatever pathway the buyer has funded next, if any.
- Whether the employer, the health plan or the member pays depends on the contract route, and members frequently do not know which applies to them until they receive a bill or discover they do not.
- A structured programme demands daily engagement, and members who cannot sustain that get much less than the outcome data implies, because the published results reflect members who completed.
- The heart rate variability device is a differentiator but also a logistics and support burden, adding shipping, returns and device support to what would otherwise be a software deployment.
- Meru is small relative to Lyra, Spring Health and the large payer owned behavioural health offerings, so an employer choosing it takes on more vendor concentration risk in a category that has seen frequent consolidation.
Pricing, plan by plan
Annalise.ai
On request- Annalise Enterprise$undefined/year
- Priced per study analysed or as an annual volume subscription
- CXR and CTB licensed separately
- Cleared finding set differs by market, which changes what you are buying
Meru Health
On request- Meru Health$undefined/year
- Contracted per completed programme or per member per month depending on buyer type
- Health plan contracts bill differently from employer contracts
- Member cost sharing depends on whether access comes via insurance or an employer benefit
Which should you pick?
Choose Annalise.ai if
- You need annalise enterprise cxr.
- You work on Web, Cloud, On-premise.
- You also want annalise enterprise ctb.
Choose Meru Health if
- You need twelve week structured programme.
- You work on Web, iOS, Android.
- You also want licensed therapist.
Questions people ask
- Is Annalise.ai or Meru Health better?
- Neither clearly leads. Annalise.ai starts at On request and Meru Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Annalise.ai or Meru Health?
- Annalise.ai starts at On request and Meru Health at On request.
- Does Annalise.ai or Meru Health run on more platforms?
- Annalise.ai runs on Web, Cloud, On-premise. Meru Health runs on Web, iOS, Android.
- What is Annalise.ai best used for?
- Annalise.ai is most often used for an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest, a teleradiology provider covering many small hospitals that needs consistent triage before a human reads, a screening programme in europe where the broader ce marked decision support indication, rather than the narrow united states triage clearance, is what is being deployed, a radiology department building an ai governance programme that wants one vendor covering both chest radiograph and head ct rather than contracting two separate algorithm suppliers. Of those, an emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnest and a teleradiology provider covering many small hospitals that needs consistent triage before a human reads are not what Meru Health is typically brought in for.
- What can Annalise.ai do that Meru Health cannot?
- Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation. Meru Health covers Twelve week structured programme, Licensed therapist, Psychiatric consultation, HRV biofeedback device.
Answered from the vendors’ own pages
Annalise.ai: How many findings are FDA cleared?
Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.
Meru Health: Is Meru Health still operating?
Yes. It launched Meru Health Advanced in May 2026 and expanded its Harvard Pilgrim Health Care collaboration in 2025. It has not wound down.
Annalise.ai: Is the European position different?
Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.
Meru Health: How long is the programme?
Around twelve weeks. It is a bounded treatment episode rather than open ended therapy, which is why health plans will contract for it.
Annalise.ai: Does it diagnose?
No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.
Meru Health: Who pays?
It depends on the contract. Meru sells to both health plans and employers, and member cost sharing differs between those routes. Confirm which applies before enrolling.
Annalise.ai: Is Annalise.ai becoming Harrison.ai?
The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.
Meru Health: Does it include medication?
Psychiatric consultation is part of the programme where medication is indicated, which distinguishes it from app plus coaching products that cannot prescribe.
Related pages
More on Annalise.ai
More on Meru Health
Other head to heads
- Annalise.ai vs Gleamer
- Annalise.ai vs Rad AI
- Annalise.ai vs Sectra
- Annalise.ai vs Aidoc
- Annalise.ai vs Ibex Medical Analytics
- Annalise.ai vs Paige
- Annalise.ai vs Philips IntelliSpace PACS
- Annalise.ai vs Fujifilm Synapse
- Annalise.ai vs Visage Imaging
- Annalise.ai vs Lunit
- Annalise.ai vs Techcyte
- Annalise.ai vs PathAI
- Annalise.ai vs Epocrates
- Annalise.ai vs Figure 1
- Annalise.ai vs Fullscript
- Annalise.ai vs GNU Health
- Annalise.ai vs GoodRx
- Annalise.ai vs Halaxy
- Annalise.ai vs Lyra Health
- Annalise.ai vs SilverCloud by Amwell
- Annalise.ai vs Koa Health
- Annalise.ai vs Woebot Health
- Annalise.ai vs TheraNest
- Annalise.ai vs BetterHelp
- Annalise.ai vs SimplePractice
- Annalise.ai vs Ginger
- Annalise.ai vs TherapyNotes
- Annalise.ai vs Talkspace
- Annalise.ai vs MDLive
- Annalise.ai vs Headspace
- Annalise.ai vs eClinicalWorks Prime
- Meru Health vs Gleamer
- Meru Health vs Rad AI
- Meru Health vs Sectra
- Meru Health vs Aidoc
- Meru Health vs Ibex Medical Analytics
- Meru Health vs Paige
- Meru Health vs Philips IntelliSpace PACS
- Meru Health vs Fujifilm Synapse
- Meru Health vs Visage Imaging
- Meru Health vs Lunit
- Meru Health vs Techcyte
- Meru Health vs PathAI
- Meru Health vs Epocrates
- Meru Health vs Figure 1
- Meru Health vs Fullscript
- Meru Health vs GNU Health
- Meru Health vs GoodRx
- Meru Health vs Halaxy
- Meru Health vs Lyra Health
- Meru Health vs SilverCloud by Amwell
- Meru Health vs Koa Health
- Meru Health vs Woebot Health
- Meru Health vs TheraNest
- Meru Health vs BetterHelp
- Meru Health vs SimplePractice
- Meru Health vs Ginger
- Meru Health vs TherapyNotes
- Meru Health vs Talkspace
- Meru Health vs MDLive
- Meru Health vs Headspace
- Meru Health vs eClinicalWorks Prime
